Cargando…

Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis

Bronchiectasis is a common feature of severe inherited and acquired pulmonary disease conditions. Among inherited diseases, cystic fibrosis (CF) is the major disorder associated with bronchiectasis, while acquired conditions frequently featuring bronchiectasis include post-infective bronchiectasis a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schäfer, Jürgen, Griese, Matthias, Chandrasekaran, Ravishankar, Chotirmall, Sanjay H., Hartl, Dominik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964733/ https://www.ncbi.nlm.nih.gov/pubmed/29788954 http://dx.doi.org/10.1186/s12890-018-0630-8

Ejemplares similares

Bronchiectasis in PCD looks different to CF on CT scan
por: Robinson, Philip, et al.
Publicado: (2018)

The etiologies of non-CF bronchiectasis in childhood: a systematic review of 989 subjects
por: Brower, Kelly S, et al.
Publicado: (2014)

Two cases of non-cystic fibrosis (CF) bronchiectasis with allergic bronchopulmonary aspergillosis
por: De, Hriday, et al.
Publicado: (2016)

Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis
por: Chandrasekaran, Ravishankar, et al.
Publicado: (2018)

Asthma-Like Features and Anti-Asthmatic Drug Prescription in Children with Non-CF Bronchiectasis
por: Douros, Konstantinos, et al.
Publicado: (2020)

PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa
por: Burr, Lucy D., et al.
Publicado: (2018)

Theoretical insight into OH- and Cl-initiated oxidation of CF(3)OCH(CF(3))(2) and CF(3)OCF(2)CF(2)H & fate of CF(3)OC(X•)(CF(3))(2) and CF(3)OCF(2)CF(2)X• radicals (X=O, O(2))
por: Bai, Feng-Yang, et al.
Publicado: (2017)

SERCA2 Regulates Non-CF and CF Airway Epithelial Cell Response to Ozone
por: Ahmad, Shama, et al.
Publicado: (2011)

Uncovering Differences in Virulence Markers Associated with Achromobacter Species of CF and Non-CF Origin
por: Filipic, Brankica, et al.
Publicado: (2017)

Comparative effects of CFTR modulators on phagocytic, metabolic and inflammatory profiles of CF and nonCF macrophages
por: Aridgides, Daniel S., et al.
Publicado: (2023)

Inspiratory Flows and Volumes in Subjects with Non-CF Bronchiectasis Using a New Dry Powder Inhaler Device
por: Elkins, Mark R., et al.
Publicado: (2014)

The Predictive Role of Psychological Status and Disease Severity Indexes on Quality of Life Among Patients with Non-CF Bronchiectasis
por: Ceyhan, Berrin, et al.
Publicado: (2022)

Comparisons of resistance of CF and Non-CF pathogens to Hydrogen Peroxide and Hypochlorous Acid Oxidants In Vitro
por: Bonvillain, Ryan W, et al.
Publicado: (2011)

Evaluation of tests to predict metallo-β-lactamase in cystic fibrosis (CF) and non-(CF) Pseudomonas
por: Perez, Leandro Reus Rodrigues, et al.
Publicado: (2014)

492: CF innate immune defect affects CF intestinal microbiota
por: Scull, C., et al.
Publicado: (2021)

Rehabilitation Programs for Cystic Fibrosis – View from a CF Center
por: Griese, M, et al.
Publicado: (2010)

Trifluoromethyl Thianthrenium Triflate: A Readily Available Trifluoromethylating Reagent with Formal CF(3)(+), CF(3)(•), and CF(3)(–) Reactivity
por: Jia, Hao, et al.
Publicado: (2021)

Gene therapy for CF.
por: Eubanks, M
Publicado: (2001)

Multicenter Intestinal Current Measurements in Rectal Biopsies from CF and Non-CF Subjects to Monitor CFTR Function
por: Clancy, John P., et al.
Publicado: (2013)

Clinical Aspergillus Signatures in COPD and Bronchiectasis
por: Tiew, Pei Yee, et al.
Publicado: (2022)

Survey of CF mutations in the clinical laboratory
por: Huber, Klaus Roland, et al.
Publicado: (2002)

Manifestation of clustering in the $^{252}Cf(sf)$ and $^{249}Cf(n_{th},f)$ reactions
por: Pyatkov, Yu V, et al.
Publicado: (1996)

Bronchiectasis: an emerging global epidemic
por: Chotirmall, Sanjay H., et al.
Publicado: (2018)

General, Practical and Selective Oxidation Protocol for CF(3)S into CF(3)S(O) Group
por: Sokolenko, Liubov V., et al.
Publicado: (2019)

Access to N−CF(3) Formamides by Reduction of N−CF(3) Carbamoyl Fluorides
por: Zivkovic, Filip G., et al.
Publicado: (2022)

Stratifying Bronchiectasis: Getting to within a Zone’s Throw
por: Chotirmall, Sanjay H.
Publicado: (2019)

Influence of Molecular Parameters on Rate Constants of Thermal Dissociation/Recombination Reactions: The Reaction System CF(4) ⇄ CF(3) + F
por: Cobos, Carlos J., et al.
Publicado: (2023)

Professor C.F. Powell
Publicado: (1969)

Class 1 CF Mutations
por: Wilschanski, Michael
Publicado: (2012)

Psychological Impact of NBS for CF
por: Chudleigh, Jane, et al.
Publicado: (2020)

Unusual presentation of CF in an infant
por: Portillo Miño, José Dario, et al.
Publicado: (2020)

The virtual CF clinic: Implications for sputum microbiology
por: Moore, John E., et al.
Publicado: (2021)

The Role of Receptor for Advanced Glycation End Products in Airway Inflammation in CF and CF related Diabetes
por: Mulrennan, Siobhain, et al.
Publicado: (2015)

A CF patient with progressive proteinuric renal disease: a CF-specific nodular glomerulosclerosis?
por: O’Connell, Oisin, et al.
Publicado: (2010)

Hot topics and current controversies in non-cystic fibrosis bronchiectasis
por: Severiche-Bueno, Diego, et al.
Publicado: (2019)

Speech by Professor C.F. Powell
Publicado: (1964)

Acute and Chronic Infection Management in CF
por: Allen, Patrick, et al.
Publicado: (2020)

CF Patient’s Pneumothoraxes Unique Genes
por: McKee, Jillian, et al.
Publicado: (2016)

239: Perspectives of people with CF and caregivers regarding medication access and telehealth in CF care during the COVID-19 pandemic
por: Phan, H., et al.
Publicado: (2021)

Activation of chloride transport in CF airway epithelial cell lines and primary CF nasal epithelial cells by S-nitrosoglutathione
por: Servetnyk, Zhanna, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_jnu45b9lfac31081kkmut1sng5